TIZANIDINE axapharm cpr 2 mg 100 pce
7680692600028
CH-69260
M03BX02
01.12.0.
1 / 2
google
Details
- Product number
- 6926001
- CPT
- -
- Packaging group
- 100
- Unit
- Tablette(n)
- Composition
- tizanidinum 2.0 mg ut tizanidini hydrochloridum, lactosum monohydricum 106.79 mg, amylum pregelificatum, macrogolum 4000, acidum stearicum, saccharum 11.76 mg, magnesii stearas, pro compresso.
Articles (1)
Tizanidin axapharm 2 mg, Tabletten
Tabletten
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
106.79 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
11.76 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 30.80
Specialties list
Yes
Generic
Yes
SL addition date:
01/10/2023
Authorization holder
axapharm ag
6340 Baar
Authorization information
- Swissmedic authorization number
- 69260
- Drug name
- Tizanidin axapharm, Tabletten
- Galenic form
- TAB
- ATC Code
- M03BX02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 20/06/2023
- Authorization expiration date
- 19/06/2028
- IT number
- 01.12.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TIZANIDINE axapharm cpr 2 mg 100 pce
- Description (DE)
- TIZANIDIN axapharm Tabl 2 mg 100 Stk
- Market launch
- 20/06/2023
- Narcotic (BTM)
- No